Drawing based on the description in the official product monograph. No photo yet.
“200 mg capsules are with light yellow opaque colored cap and body imprinted with RDY on cap and 200 on body in black ink”
RDY pill
Pill with imprint RDY is yellow, capsule and has been identified as Nilotinib Hydrochloride Monohydrate 200 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by DR Reddy's Laboratories Ltd.
Sold in Canada
Nilotinib Hydrochloride Monohydrate 200 mg
- Brand
- Reddy-Nilotinib
- Imprint
- RDY
- Strength
- 200 mg
- Used for
- Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
- Color
- Yellow
- Shape
- Capsule / oblong
- Form
- Capsule
- Manufacturer
- DR Reddy's Laboratories Ltd
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02556642
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows RDY.
- It is yellow, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Reddy-Nilotinib by DR Reddy’s Laboratories Ltd.
In Canada: prescription only.
Ingredients
Active: Nilotinib (Nilotinib Hydrochloride Monohydrate)
Other pills with imprint RDY
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
266 18
Atomoxetine 18 mg
White & yellow, capsule, 19 mm
Used for ADHD
-
Y203 60mg
Duloxetine Hydrochloride 60 mg
Blue & yellow, capsule, 19 mm
Used for nerve pain from diabetes and anxiety
-
Y201 20mg
Duloxetine Hydrochloride 20 mg
Yellow, capsule, 14 mm
Used for nerve pain from diabetes and anxiety
-
G443 G443
Dantrolene Sodium 100 mg
Red & yellow, capsule, 19 mm
Used for multiple sclerosis and muscle stiffness (spasticity)
-
G442 G442
Dantrolene Sodium 50 mg
Blue & yellow, capsule, 18 mm
Used for multiple sclerosis and muscle stiffness (spasticity)
-
G441 G441
Dantrolene Sodium 25 mg
Green & yellow, capsule, 16 mm
Used for multiple sclerosis and muscle stiffness (spasticity)
Other Nilotinib pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 23 Nilotinib 150 mg Pink, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 031150mg Nilotinib 150 mg Red, capsule, 20 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia